NCT00872898 - Study of Pharmacokinetics, Safety, Efficacy, and Tolerability of Memantine in Children With Autism | Biotech Hunter

Enrollment

124

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

August 31, 2012

Conditions

Autism

Interventions

DRUG

Memantine - Extended Release (ER)

Memantine - 3mg and 6mg capsules, dose ranging 3 - 18 mg/day in 4 weight groups, administered orally.

DRUG

Placebo

Placebo capsules, once daily, oral administration.

Trial Locations (17)

11030

Forest Investigative Site, Manhasset

32250

Forest Investigative Site, Jacksonville Beach

33701

Forest Investigative Site, St. Petersburg

43210

Forest Investigative Site, Columbus

44106

Forest Investigative Site, Cleveland

46202

Forest Investigative Site, Indianapolis

60169

Forest Investigative Site, Hoffman Estates

60563

Forest Investigative site, Naperville

73116

Forest Investigative Site, Oklahoma City

85006

Forest Investigative Site, Phoenix

92705

Forest Investigative Site, Santa Ana

94143

Forest Investigative Site, San Francisco

94305

Forest Investigative Site, Stanford

95817

Forest Investigative Site, Sacramento

02138

Forest Investigative Site, Cambridge

08755

Forest Investigative Site, Toms River

08043

Forest Investigative Site, Voorhees Township